Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.01 per share
-
Shares outstanding
-
46.2M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
14.2M
-
Shares change
-
+7.66K
-
Total reported value, excl. options
-
$473M
-
Value change
-
+$4.84M
-
Put/Call ratio
-
0.89
-
Number of buys
-
47
-
Number of sells
-
-28
-
Price
-
$33.37
Significant Holders of UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) as of Q4 2019
96 filings reported holding URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share as of Q4 2019.
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.2M shares
of 46.2M outstanding shares and own 30.67% of the company stock.
Largest 10 shareholders include MENORA MIVTACHIM HOLDINGS LTD. (2.95M shares), BlackRock Inc. (1.37M shares), WELLINGTON MANAGEMENT GROUP LLP (1.22M shares), Wildcat Capital Management, LLC (1.16M shares), HIGHLINE CAPITAL MANAGEMENT, L.P. (849K shares), Phoenix Holdings Ltd. (835K shares), BAKER BROS. ADVISORS LP (831K shares), Migdal Insurance & Financial Holdings Ltd. (738K shares), CREDIT SUISSE AG/ (669K shares), and STATE STREET CORP (412K shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.